Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenoviridae | 5 | 2007 | 1095 | 0.750 |
Why?
|
| Cell Hypoxia | 4 | 2005 | 662 | 0.550 |
Why?
|
| Integrative Medicine | 2 | 2016 | 87 | 0.480 |
Why?
|
| Hypoxia-Inducible Factor 1 | 4 | 2007 | 193 | 0.420 |
Why?
|
| Oncolytic Viruses | 2 | 2007 | 345 | 0.400 |
Why?
|
| Virus Replication | 5 | 2005 | 2458 | 0.370 |
Why?
|
| Oncolytic Virotherapy | 2 | 2007 | 521 | 0.350 |
Why?
|
| Genetic Vectors | 4 | 2004 | 3412 | 0.350 |
Why?
|
| Complementary Therapies | 1 | 2012 | 487 | 0.300 |
Why?
|
| Low Back Pain | 3 | 2012 | 990 | 0.290 |
Why?
|
| Dibenzothiazepines | 1 | 2007 | 102 | 0.270 |
Why?
|
| Glioma | 4 | 2004 | 3532 | 0.240 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2004 | 81 | 0.240 |
Why?
|
| Interleukin-4 | 1 | 2007 | 1157 | 0.210 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 2434 | 0.200 |
Why?
|
| Drug Resistance | 1 | 2007 | 1599 | 0.180 |
Why?
|
| Patient Care Team | 1 | 2012 | 2528 | 0.180 |
Why?
|
| Violence | 1 | 2007 | 936 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2004 | 5804 | 0.170 |
Why?
|
| Herpesvirus 1, Human | 1 | 2004 | 744 | 0.150 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9618 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2004 | 627 | 0.130 |
Why?
|
| Brain Neoplasms | 3 | 2004 | 9213 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 2007 | 3081 | 0.110 |
Why?
|
| Neoplasms | 5 | 2005 | 22389 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 4 | 2004 | 6131 | 0.100 |
Why?
|
| Duty to Warn | 1 | 1992 | 30 | 0.100 |
Why?
|
| Jurisprudence | 1 | 1992 | 109 | 0.100 |
Why?
|
| Social Control, Formal | 1 | 1992 | 107 | 0.090 |
Why?
|
| Psychotic Disorders | 1 | 2007 | 3278 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2004 | 12174 | 0.090 |
Why?
|
| Law Enforcement | 1 | 1992 | 112 | 0.090 |
Why?
|
| Gentamicins | 1 | 1991 | 244 | 0.090 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 997 | 0.090 |
Why?
|
| Confidentiality | 1 | 1992 | 606 | 0.070 |
Why?
|
| Manipulation, Chiropractic | 1 | 2007 | 24 | 0.070 |
Why?
|
| Massage | 1 | 2007 | 86 | 0.070 |
Why?
|
| HIV Seropositivity | 1 | 1992 | 967 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2784 | 0.060 |
Why?
|
| Disclosure | 1 | 1992 | 755 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 8664 | 0.060 |
Why?
|
| Carmustine | 1 | 2004 | 137 | 0.060 |
Why?
|
| Education, Medical | 1 | 2016 | 1742 | 0.060 |
Why?
|
| Risperidone | 1 | 2007 | 383 | 0.060 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2004 | 34 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2004 | 8559 | 0.060 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 2018 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1991 | 1276 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2005 | 288 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 414 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 5801 | 0.050 |
Why?
|
| Quinones | 1 | 2002 | 78 | 0.050 |
Why?
|
| Acupuncture Therapy | 1 | 2007 | 486 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2004 | 3518 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 97 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 4168 | 0.050 |
Why?
|
| Culture Media | 2 | 1995 | 898 | 0.050 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2004 | 618 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2007 | 1138 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2001 | 751 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 674 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 1074 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2005 | 1161 | 0.040 |
Why?
|
| Lymphokines | 1 | 2001 | 927 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 1793 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2012 | 8748 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2004 | 3631 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2002 | 682 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2007 | 3492 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1524 | 0.040 |
Why?
|
| Cell Survival | 1 | 2007 | 5793 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2007 | 3449 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2001 | 718 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6320 | 0.030 |
Why?
|
| Humans | 18 | 2016 | 768970 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2004 | 3621 | 0.030 |
Why?
|
| Forecasting | 1 | 2005 | 2945 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 17173 | 0.030 |
Why?
|
| Campylobacter | 1 | 1995 | 58 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 3554 | 0.030 |
Why?
|
| Food Microbiology | 1 | 1995 | 74 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2812 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 2634 | 0.030 |
Why?
|
| Transfection | 1 | 2001 | 5763 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 4056 | 0.030 |
Why?
|
| Agar | 1 | 1991 | 51 | 0.020 |
Why?
|
| Civil Rights | 1 | 1992 | 131 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2005 | 3525 | 0.020 |
Why?
|
| Privacy | 1 | 1992 | 233 | 0.020 |
Why?
|
| Organizational Policy | 1 | 1992 | 435 | 0.020 |
Why?
|
| Social Responsibility | 1 | 1992 | 384 | 0.020 |
Why?
|
| Mice | 2 | 2007 | 82072 | 0.020 |
Why?
|
| State Government | 1 | 1992 | 389 | 0.020 |
Why?
|
| Prisoners | 1 | 1992 | 316 | 0.020 |
Why?
|
| Adult | 4 | 2012 | 223851 | 0.020 |
Why?
|
| Prejudice | 1 | 1992 | 574 | 0.020 |
Why?
|
| Animals | 4 | 2007 | 169335 | 0.020 |
Why?
|
| Acute Disease | 2 | 2007 | 7245 | 0.020 |
Why?
|
| Goals | 1 | 1992 | 717 | 0.020 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2005 | 21 | 0.020 |
Why?
|
| Health Education | 1 | 1992 | 1059 | 0.020 |
Why?
|
| Male | 5 | 2012 | 365203 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1991 | 1967 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 200 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 731 | 0.010 |
Why?
|
| Middle Aged | 3 | 2012 | 223737 | 0.010 |
Why?
|
| Benzoquinones | 1 | 2002 | 198 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 23653 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 2002 | 319 | 0.010 |
Why?
|
| ras Proteins | 1 | 2005 | 1058 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2002 | 423 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 11230 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 30266 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2005 | 1120 | 0.010 |
Why?
|
| Female | 4 | 2012 | 397515 | 0.010 |
Why?
|
| Public Health | 1 | 1992 | 2680 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2007 | 3586 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4592 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 5033 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2460 | 0.010 |
Why?
|
| United States | 2 | 2016 | 73186 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4148 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 3744 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 1995 | 277 | 0.010 |
Why?
|
| Decision Making | 1 | 2007 | 3953 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2007 | 3270 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4528 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3608 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54962 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7603 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 65480 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 15604 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 13048 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 10765 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15951 | 0.010 |
Why?
|
| Temperature | 1 | 1995 | 2235 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 8055 | 0.000 |
Why?
|
| Apoptosis | 1 | 2004 | 9527 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 7609 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5443 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 39394 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 21188 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1995 | 7478 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_